June 15-17, 2016
The goal of the 2016 MISAM is to reflect the tremendous progress that has occurred during recent years in understanding and therapeutic modulation of the advanced cancer epigenome. Participants will discuss new insights into key epigenetic processes that are commonly deregulated during cancer formation and metastatic progression. Novel therapeutic avenues targeting the epigenome will be explored, to better combat systemic propagation of cancers.
For more info and to register, click here.
May 12, 2016